Carol Dore- Falcone

Avg. Two Year Performance

No purchase track record
2% Avg. Sale Return
1% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(48%)(52%)(68%)(23%)2%
Sale Success Rate1 of 31 of 31 of 31 of 32 of 3
Drugs » Drug Manufacturers - Major

Senior Vice-President & CFO, Director:

Holdings: 757.26K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--